Introduction
Asian CTD (ACTD) MCQs With Answer is a focused quiz collection designed for M.Pharm students studying Documentation & Regulatory Writing. This set emphasises the ASEAN/Common Technical Dossier concept and its alignment with the ICH CTD, addressing module structure, regional variations, dossier components, and practical submission requirements. The questions are curated to deepen understanding of where key documents belong (quality, nonclinical, clinical, and regional administrative parts), regulatory expectations such as GMP/CPP requirements, and the role of summaries and bridging reports. Use these MCQs to test knowledge, prepare for examinations, and build practical insight for preparing regulatory submissions across Asian regulatory authorities.
Q1. What does ACTD commonly stand for in the context of Asian regulatory dossiers?
- Asian Clinical Trial Dossier
- ASEAN Common Technical Dossier (ACTD)
- Approved Clinical Technical Document
- Asia-wide Common Technical Directive
Correct Answer: ASEAN Common Technical Dossier (ACTD)
Q2. Which ACTD module is considered region- or country-specific and is not harmonized across all participating countries?
- Module 1
- Module 2
- Module 3
- Module 5
Correct Answer: Module 1
Q3. The ACTD aligns most closely with which part(s) of the ICH CTD?
- Only Module 3 (Quality)
- Modules 2–5 (Summaries, Quality, Nonclinical, Clinical)
- Only Module 1 (Administrative)
- None of the ICH CTD modules
Correct Answer: Modules 2–5 (Summaries, Quality, Nonclinical, Clinical)
Q4. Which module of the ACTD primarily contains detailed drug substance and drug product manufacturing, control, and stability data?
- Module 1 — Administrative information
- Module 3 — Quality (pharmaceutical) documentation
- Module 4 — Nonclinical study reports
- Module 5 — Clinical study reports
Correct Answer: Module 3 — Quality (pharmaceutical) documentation
Q5. Which of the following is typically included in ACTD Module 1?
- Quality Overall Summary
- Nonclinical study reports
- Administrative documents, product labeling and local application forms
- Clinical study reports and statistical analyses
Correct Answer: Administrative documents, product labeling and local application forms
Q6. What does CPP stand for and why is it commonly requested in ACTD submissions?
- Certificate of Pharmaceutical Product — to confirm product authorization and standards in the exporting country
- Clinical Pharmacology Plan — to document study protocols
- Current Product Price — to establish market pricing
- Certificate of Product Purity — to confirm impurity limits
Correct Answer: Certificate of Pharmaceutical Product — to confirm product authorization and standards in the exporting country
Q7. Which document is most often requested in an ACTD to demonstrate the manufacturer complies with Good Manufacturing Practice?
- Free Sale Certificate
- GMP Certificate issued by the manufacturing country’s regulatory authority
- Bioequivalence study report
- Clinical overview
Correct Answer: GMP Certificate issued by the manufacturing country’s regulatory authority
Q8. Where in the ACTD should bioequivalence or bioavailability study reports for a generic product be placed?
- Module 1 — Administrative information
- Module 3 — Quality section
- Module 5 — Clinical study reports
- Module 2 — Table of contents only
Correct Answer: Module 5 — Clinical study reports
Q9. The main structural distinction between ACTD and the original ICH CTD is:
- The technical content of Modules 2–5 is completely different
- Module 1 is region-specific in ACTD while Modules 2–5 follow CTD harmonization
- ACTD eliminates the need for quality data entirely
- ACTD requires clinical data in Module 3
Correct Answer: Module 1 is region-specific in ACTD while Modules 2–5 follow CTD harmonization
Q10. What is the meaning of eCTD in regulatory submissions, and how does it relate to ACTD?
- electronic Common Technical Document — an electronic format often used to submit ACTD content
- enhanced Clinical Trial Dossier — a separate clinical-only format
- electronic Clinical Trial Directive — used only for clinical trial approvals
- extended Chemistry and Toxicology Dossier — an expanded Module 3
Correct Answer: electronic Common Technical Document — an electronic format often used to submit ACTD content
Q11. Where would you place the Clinical Overview and Clinical Summary in the ACTD?
- Module 1 — Administrative
- Module 2 — Overviews and Summaries
- Module 3 — Quality
- Module 4 — Toxicology
Correct Answer: Module 2 — Overviews and Summaries
Q12. What is the purpose of a bridging report in the context of ACTD submissions?
- To summarize stability data only
- To connect and justify foreign clinical or nonclinical data for local relevance
- To provide additional manufacturing batch records
- To replace the need for Module 3 information
Correct Answer: To connect and justify foreign clinical or nonclinical data for local relevance
Q13. In ACTD preparation, how should the dossier sections be numbered and organised for clarity and regulatory review?
- Use an internal proprietary numbering system unique to the company
- Follow CTD hierarchical numbering (Module.Submodule.Section) consistent with ICH CTD conventions
- Number only Module 1 and leave others unnumbered
- Combine Modules 2–5 into one document with continuous pagination
Correct Answer: Follow CTD hierarchical numbering (Module.Submodule.Section) consistent with ICH CTD conventions
Q14. The Quality Overall Summary (QOS) is found in which section of the ACTD?
- Module 1 — Administrative documents
- Module 2 — Quality Overall Summary (QOS)
- Module 4 — Nonclinical summaries
- Module 5 — Clinical trial reports
Correct Answer: Module 2 — Quality Overall Summary (QOS)
Q15. Where are full nonclinical study reports (pharmacology and toxicology) placed within the ACTD?
- Module 1 — Administrative information
- Module 3 — Quality reports
- Module 4 — Nonclinical study reports
- Module 5 — Clinical summaries
Correct Answer: Module 4 — Nonclinical study reports
Q16. The primary objective of implementing an ACTD for ASEAN regulators is to:
- Replace national laws with a single ASEAN law
- Harmonize dossier structure and streamline regulatory review across member countries
- Eliminate the need for clinical data
- Standardize drug pricing across ASEAN
Correct Answer: Harmonize dossier structure and streamline regulatory review across member countries
Q17. Which ACTD elements typically require local language translation or localization?
- Module 3 technical specifications only
- Labels, patient information leaflets, and some Module 1 administrative forms
- Nonclinical study raw data only
- Quality Overall Summary only
Correct Answer: Labels, patient information leaflets, and some Module 1 administrative forms
Q18. Where in the ACTD would you include detailed manufacturing process descriptions and in-process controls for the drug substance?
- Module 1 — Administrative data
- Module 2 — Clinical overview
- Module 3 — Drug substance and drug product manufacturing and control
- Module 4 — Toxicology reports
Correct Answer: Module 3 — Drug substance and drug product manufacturing and control
Q19. Which of the following statements best describes national acceptance of ACTD across Asian regulatory authorities?
- All Asian countries accept ACTD with identical national requirements and no deviations
- ACTD provides a common format but individual countries may request additional national-specific documents or data
- ACTD replaces all national submission requirements immediately upon adoption
- ACTD excludes Module 3 requirements when submitting to Asian regulators
Correct Answer: ACTD provides a common format but individual countries may request additional national-specific documents or data
Q20. Which of the following is commonly required as part of Module 1 administrative documentation when submitting an ACTD to several ASEAN member states?
- Clinical study raw datasets only
- Power of Attorney or letter of authorization for local agent, country-specific application forms, and product labeling
- Detailed impurity structure elucidation in Module 5
- None — Module 1 is optional for ACTD submissions
Correct Answer: Power of Attorney or letter of authorization for local agent, country-specific application forms, and product labeling
